Description
IXAZOMIB MAINTENANCE SIGNIFICANTLY DELAYS DISEASE PROGRESSION FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA
€2.42
IXAZOMIB MAINTENANCE SIGNIFICANTLY DELAYS DISEASE PROGRESSION FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Reviews
There are no reviews yet.